RazorMetrics Expands Executive Team

RazorMetrics™

Share This Post

Austin health-tech startup is growing quickly amid rampant tech layoffs.

AUSTIN, TX, March 9, 2023 – RazorMetrics, a rapidly growing healthcare technology company focused on lowering drug spend for self-insured employers and health plans, is expanding its executive team to meet the demand of organizational growth and new, large clients. As budgets tighten around the country, RazorMetrics’ platform helps companies cut drug spend instead of headcount.

“It’s great to be expanding at a time when many tech companies are contracting,” said Tom Dorsett, CEO and Founder of RazorMetrics. “We’ve added these very talented individuals to our executive team in order to meet the needs of our rapidly growing client base comprised of millions of employees.”

Gary Epple, the person behind RazorMetrics’ product development strategy and implementation, will be taking on a new role as Chief Operating Officer of RazorMetrics. Mr. Epple’s 30+ years of experience in technology development will be instrumental in launching and maintaining engagements with numerous Fortune 100 companies. “RazorMetrics created a measurable and effective technology solution to explore prescription alternatives, and I’m excited to see how far we can take this cutting-edge platform.”

“It’s great to be expanding at a time when many tech companies are contracting,”

Tom Dorsett, CEO

Kashif Dastgir was brought on as the new Vice President of Development based on his experience as a seasoned engineering leader with 25+ years of experience working with major technology companies, including Microsoft and Oracle, in the USA, Pakistan, Netherlands, Ireland, and UAE. His hands-on experience with design and architecture of applications and microservices related to cloud infrastructure and machine learning will be a significant asset to RazorMetrics’ team.

Peter Kruger has joined the company as the new Vice President of Client Operations. He has 15 years of experience in healthcare technology and operations management and has held a variety of leadership roles in healthcare technology companies, including Optum and Vivify Health. In these roles, he oversaw large-scale projects, developing and implementing operational strategies and ensuring regulatory compliance.

About RazorMetrics
RazorMetrics is a healthcare technology company whose SaaS-based platform uses AI to lower drug spend for health plans, self-insured employers, and organizations. RazorMetrics’ unique, physician-driven approach process that is simple, requires no extra clicks in the EHR and no external programs or apps to access. Switches are straightforward, easy to make, and the entire process stays within the normal clinical workflow. The platform is complementary to existing pharmacy initiatives and works with PBMs and other drug cost savings solutions to optimize results. RazorMetrics is fully scalable and customizable to each client’s unique variables and formularies.  For more information, visit razormetrics.com.

More To Explore

Article

Employer Benefit Costs Going Up in 2025

Analysts predict another difficult year for employers as health benefit costs are slated to rise by 5.8% Mercer’s recent “National Survey of Employer Sponsored Health Plans” predicts the surge in 2025 will mimic the increases seen in 2023 and 2024. The substantial annual increase is a shift from previous decades, where annual increases hovered around 3%. Without implementing cost-cutting measures, employees could see a jump in their premiums and copays.

Article

A New Way to Manage the GLP-1 Explosion

GLP-1 receptor agonists are all the rage these days for the promise of easy weight loss. GLP1s are FDA-approved for managing Type 2 diabetes but physicians are prescribing the medication for off-label use to help their patients lose weight. Between 2020 and 2023, the use of GLP-1 medications such as Ozempic and Wegovy, increased sharply due to off-label prescriptions. While these medications are very effective, they are also very expensive, which is challenging insurers, employers, and patients alike. As the demand for GLP-1 drugs continues to grow, particularly for weight loss, understanding the complexities of coverage and finding cost-saving strategies has become a top priority.

Ready to Get Started?

We're Here

To Help You Save

And, we are waiting…
Contact us, and we will be more than happy to answer all of your questions.